Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail
  • Print
  • Share
  • E-mail
-
 
Pediatric Labeling Date:  03/26/2012
 
Trade Name:  Singulair Oral Granules, Tablets, and Chewable Tablets
 
Generic Name or Proper Name (*):  montelukast
 
Indications Studied:  Prevention of exercise-induced bronchoconstriction
 
Label Changes Summary:  Expanded indication to include pediatric patients from 6 - 14 years; previously approved for use in 15 years and older Efficacy for prevention of EIB in patients < 6 years of age has not been established Information on clinical trial, and dosing Postmarketing study
 
Product Labeling:  Labeling  Opens a new window
 
PREA(P):  P
 
Sponsor:  Merck
 
NNPS:  FALSE'
 
Therapeutic Category:  Antiasthmatic; antiallergy
 
-
-